David Bowen Profile
David Bowen

@MDSdocUK

Followers
181
Following
12
Media
17
Statuses
100

MDS physician for 30 years. Dabbles in cost effectiveness, regulatory medicine, real world data and genomics. Recognises the patient as a person.

England, United Kingdom
Joined April 2017
Don't wanna be here? Send us removal request.
@MDSdocUK
David Bowen
5 years
Last Friday I held a tweet chat with @MDS_UK in honour of #MDSWAD to raise awareness of the impact of MDS and the benefits of patient involvement in research. If you missed it (or want to relive it!), you can READ the full discussion here:
0
3
7
@MDSdocUK
David Bowen
5 years
Congratulations to all. The patient voice was strong in designing this study. A model for all trial development going forward. Thank you to Sophie and her team
@MDS_UK
MDSUK Patient Support 🩸
5 years
We were particularly pleased to have contributed #PPI feedback for the successfull approval of this very interesting #MDS #Clinicaltrial. Looking forward to help enrol patients too.
0
0
3
@MDSdocUK
David Bowen
5 years
Encouraging data - good incentive for all active sites to continue recruitment to iMERGE phase 3 trial, accepting current challenges with trial recruitment #leedshaem
@DavidSteensma
David Steensma, MD
5 years
Our MDS3001 trial of imetelstat in transfusion dependent #MDS pts is now online @JCO_ASCO: 37% 8-week RBC TI rate, slightly higher rate in HMA/len-naive subset, a number of patients had reduction in clone size during treatment. Phase 3 ongoing. $GERN
0
0
3
@MDSdocUK
David Bowen
5 years
Our European MDS Registry project has been accepted onto the UK NIHR research trial portfolio. Good to see that registries are gathering research currency, recognising valuable complementary role to clinical trials #MDS_EUROPE
0
0
9
@MDSdocUK
David Bowen
5 years
Save the date! To mark #MDSWAD we’re hosting a tweet chat around patient involvement in research in #myelodysplastic syndromes on 30 Oct at 12pm GMT @MDS_UK & @MDSdocUK. Join us at #SilenceMDSChat
0
1
9
@CureLeukaemia
Cure Leukaemia
6 years
Recommendations for the management of patients with AML during the COVID-19 outbreak: A statement from the NCRI AML Working Party: https://t.co/CkhPLwYcgC #COVID19 #COVIDー19 #covid19UK #AML #kNOwAML #AML #Bloodcancer #Haematology
0
14
15
@MDSdocUK
David Bowen
6 years
ELN symposium, EBMT postponed. Any societies attempting webcasts or similar virtual meetings? Preempt the future - perfect opportunity going to waste. At least video consults will become mainstream - long overdue and works well for MDS specialist consults @leedshaem @MDS_UK
1
8
16
@EricTopol
Eric Topol
6 years
"Our government is complicit in an extortion that is an important contributor to income inequality in America today."—Anne Case & @DeatonAngus @TIME "The Sickness of Our System" https://t.co/1EoCWemxoR redrawn graph from @MaxCRoser, what I've also been writing about for some time
5
68
140
@DrSDNimer
Stephen D. Nimer, MD
6 years
Thrilled to co-moderate a fantastic session on #MDS sponsored by ⁦@MDSFoundation⁩ with Dr. Mario Cazzola. Packed house at 7 am. Thanks to all the amazing speakers ⁦and to the audience participants who made the session lively & informative.
0
2
14
@TaylorJ_MD
Taylor Lab UM
6 years
#ASH19@ColemanLindsley⁩ presents patients with #AML and TP53 mutations have poor outcomes with Vyxeos or standard treatment #leusm
2
15
33
@MDSdocUK
David Bowen
6 years
Charlie Craddock delivers a deeply personal eulogy to the legend that was David Grimwade
1
1
12
@MDSdocUK
David Bowen
6 years
Marlijn presenting important data from EUMDS programme informing transfusion and iron toxicity. Further evidence for transfusion dependence as a relatively negative prognostic factor #EHA2019
0
1
6
@MDSdocUK
David Bowen
6 years
Productive discussions at NCRI MDS subgroup. Strategy emerging with strengths in low risk MDS, registries, biobanks. Enjoying the emergence of a new generation of young UK clinician scientists. Strategy document to follow setting out research priorities #NCRI #CRUK
0
4
13
@lionelbarber
Lionel Barber
7 years
Well worth watching: Dutch historian demolishes Fox News anchor Tucker Carlson (spectacular upper cut knock out in round three) #tax #Murdoch #Koch
@nowthisimpact
NowThis Impact
7 years
Watch Fox News host Tucker Carlson call one of his guests a 'tiny brain...moron' during an interview. NowThis has obtained the full segment with historian Rutger Bregman that Fox News is refusing to air.
5
58
145
@MDSdocUK
David Bowen
7 years
Prof Dave Roberts discusses red cell genotyping including MDS. Should this now be routine? Many potential benefits but few studies. Canadian MDS data suggests may add value #BSH2019
0
1
14
@MDSdocUK
David Bowen
7 years
Dr. Simone Green telling MDS patients about new U.K. trials in MDS at Harrogate MDS Patient Forum @leedshaem @MDS_UK
0
4
11
@MDSdocUK
David Bowen
7 years
Agreed. Positive can-do culture despite financial and HR challenges of NHS. Also proud to work for LTH.
@LeedsHospitals
Leeds Teaching Hospitals
7 years
The CQC has rated us Good … and getting better! Thank you to all our staff for their hard work and commitment to improving our services and providing excellent care to our patients. https://t.co/E3UGa9o2Bq #TheLeedsWay
0
0
3
@MDSdocUK
David Bowen
7 years
Prof Fenaux presenting IWG MDS response criteria for clinical trials at ELN Annual Meeting. @MDS_EUROPE https://t.co/Tm0sGwQU20
0
4
10
@MDSdocUK
David Bowen
7 years
MDS-RIGHT / EUMDS annual symposium in Mannheim. MDS Experts in creative discussion on original research programme for patient benefit @MDS_EUROPE
0
3
17
@MDSdocUK
David Bowen
7 years
Hi Nicolas. Will complete I-Care imminently. DB
@AnitaHillLeeds
Anita Hill
7 years
An honour to be lecturing at the Haematology department at Inselspital, University Hospital in Bern. What a view of the Alps! Thanks to Prof Kremer for the invitation (not in the photo). With Profs Zeerleder, Bonadies, Baerlocher, Andres. Special hello to @MDSdocUK from Prof Bon.
0
0
3